| Particulars |
|
|
|
| Company Name
| Mankind Pharma Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
41.28 |
B.V. (₹) |
375.70 |
| Sales(₹ Cr.) |
9,497.80 |
NP (₹ Cr.) |
1,691.18 |
| NP Var% |
-4.00 |
Div% |
0.00 |
| CPS(₹) |
50.10 |
EPS (₹) |
41.00 |
| Traded Value(₹ Lakhs) |
502.80 |
52 Week High |
2,727.00 |
| 52 Week Low |
2,015.00 |
Price BSE |
2,155.00 |
| Price NSE |
2,156.00 |
Market Capital (₹ Cr.) |
88,961.56 |
| P/C Ratio |
43.00 |
P/E Ratio |
52.60 |
| Price Vs.BV |
5.74 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
2,632.68 |
| NP(₹ Cr.) |
512.82 |
NP Var % |
24.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
9,288.12 |
| OPM |
27.20 |
NP |
2,004.35 |
| NP Var% |
-9.21 |
EPS |
42.80 |
| PE |
50.35 |
|
|